Germany
Japan
United Kingdom
China
Cd2 rat monoclonal antibody, clone 12-15, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Primary Antibodies
DownloadCd3e rat monoclonal antibody, clone C363.29B (YCD3-1), APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Cd3e rat monoclonal antibody, clone C363.29B (YCD3-1), Cy5
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Cy5 |
Cd3e rat monoclonal antibody, clone C363.29B (YCD3-1), FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Cd3e rat monoclonal antibody, clone C363.29B (YCD3-1), PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD11b rat monoclonal antibody, clone 3A33, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
CD11b rat monoclonal antibody, clone 3A33, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
CD11b rat monoclonal antibody, clone 3A33, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD11b rat monoclonal antibody, clone 3A33, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd22 rat monoclonal antibody, clone 2D6, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Cd22 rat monoclonal antibody, clone 2D6, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
Cd22 rat monoclonal antibody, clone 2D6, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Cd22 rat monoclonal antibody, clone 2D6, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd24a rat monoclonal antibody, clone 91, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Cd24a rat monoclonal antibody, clone 91, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Cd24a rat monoclonal antibody, clone 91, Low Endotoxin
| Applications | FC |
| Reactivities | Mouse |
Cd24a rat monoclonal antibody, clone 91, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Il2ra rat monoclonal antibody, clone 7D4, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Il2ra rat monoclonal antibody, clone 7D4, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
Il2ra rat monoclonal antibody, clone 7D4, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Il2ra rat monoclonal antibody, clone 7D4, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Il2ra rat monoclonal antibody, clone 7D4, PE-Cy7
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE-Cy7 |
Il2ra rat monoclonal antibody, clone 7D4, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Il2ra rat monoclonal antibody, clone 7D4, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Il2ra rat monoclonal antibody, clone 3C7, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Il2ra rat monoclonal antibody, clone 3C7, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
Il2ra rat monoclonal antibody, clone 3C7, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Il2ra rat monoclonal antibody, clone 3C7, PE-Cy7
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE-Cy7 |
Il2ra rat monoclonal antibody, clone 3C7, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Il2ra rat monoclonal antibody, clone 3C7, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD16/CD32 rat monoclonal antibody, clone 93, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
CD16/CD32 rat monoclonal antibody, clone 93, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
CD16/CD32 rat monoclonal antibody, clone 93, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
CD16/CD32 rat monoclonal antibody, clone 93, PE-Cy5.5
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE-Cy5.5 |
CD16/CD32 rat monoclonal antibody, clone 93, PE-Cy7
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE-Cy7 |
CD16/CD32 rat monoclonal antibody, clone 93, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD16/CD32 rat monoclonal antibody, clone 93, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd38 rat monoclonal antibody, clone NIMR-5, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Cd38 rat monoclonal antibody, clone NIMR-5, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
Cd38 rat monoclonal antibody, clone NIMR-5, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Cd38 rat monoclonal antibody, clone NIMR-5, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd38 rat monoclonal antibody, clone NIMR-5, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd40 rat monoclonal antibody, clone 1C10, APC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | APC |
Cd40 rat monoclonal antibody, clone 1C10, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
Cd40 rat monoclonal antibody, clone 1C10, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Cd40 rat monoclonal antibody, clone 1C10, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd40 rat monoclonal antibody, clone 1C10, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD45 / LCA rat monoclonal antibody, clone I3/2.3, APC-Cy7
| Applications | IHC |
| Reactivities | Mouse |
| Conjugation | APC-Cy7 |
CD45 / LCA rat monoclonal antibody, clone I3/2.3, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
CD45 / LCA rat monoclonal antibody, clone I3/2.3, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Active filters
Antibody Hosts
- Rat
Clonalities
- Monoclonal
Filter by
Target Symbol
- ALK (50)
- MKI67 (45)
- CD86 (18)
- CD8A (14)
- BRDU (13)
- ADGRE1 (10)
- IL2RA (10)
- IDU (9)
- ACIDIC CK (8)
- EBI3 (8)
- ITGB7 (8)
- TFRC (8)
- THY1 (8)
- HAVCR2 (7)
- KIT (7)
- LY6A (7)
- CD8B1 (6)
- IL10 (6)
- IL4 (6)
- NIPBL (6)
- RAB11B (6)
- CD4 (5)
- CD5 (5)
- PTPRC (5)
- C5AR1 (4)
- CD80 (4)
- CD9 (4)
- CLASP1 (4)
- FITC (4)
- GLB1 (4)
- IL6 (4)
- KLRD1 (4)
- TCP1 (4)
- AHSA1 (3)
- CBFA2T2 (3)
- CCR7 (3)
- CD226 (3)
- CD274 (3)
- CD44 (3)
- CMKLR1 (3)
- CSF1R (3)
- IL2 (3)
- ITGA4 (3)
- ITGAM (3)
- ITGAV (3)
- LGI4 (3)
- LYL1 (3)
- MAPRE1 (3)
- MAPRE2 (3)
- MAPRE3 (3)
- PDCD1 (3)
- PDCD1LG2 (3)
- PECAM1 (3)
- RAB6B (3)
- CCL20 (2)
- CCRL2 (2)
- CD2 (2)
- CD3E (2)
- CD40 (2)
- CD52 (2)
- CD70 (2)
- ENG (2)
- FLT3 (2)
- H2-D1 (2)
- HSF1 (2)
- HSF2 (2)
- IBSP (2)
- IDH1-MUTANT (2)
- IFNGR2 (2)
- IL2RB (2)
- ITGB4 (2)
- KLRA2 (2)
- KLRB1A (2)
- KLRB1B (2)
- LAMP2 (2)
- LY6G (2)
- MHC I (2)
- SELL (2)
- SIGLEC1 (2)
- TIMD4 (2)
- TLR9 (2)
- TNFSF11 (2)
- TNFSF18 (2)
- TNFSF9 (2)
- TUBA1B (2)
- ADIPOQ (1)
- AKT2 (1)
- ANPEP (1)
- B3GALT5 (1)
- BCL11B (1)
- BID (1)
- BST1 (1)
- CCR9 (1)
- CCT2 (1)
- CD16 (FCGR3A) (1)
- CD160 (1)
- CD180 (1)
- CD19 (1)
- CD200 (1)
- CD209 (1)
Reactivities
- Mouse (310)
- Human (210)
- Rat (76)
- Sheep (9)
- Hamster (7)
- Rabbit (7)
- Canine (6)
- Monkey (6)
- Dog (5)
- Feline (5)
- Porcine (5)
- Bovine (4)
- Escherichia coli (4)
- Guinea Pig (4)
- Pig (4)
- Chicken (3)
- Cow (2)
- C. elegans (1)
- Chimpanzee (1)
- Drosophila melanogaster (1)
- Goat (1)
- Horse (1)
- Mammalian (1)
- Primate (1)
- Saccharomyces cerevisiae (1)
- Xenopus (1)
- Yeast (1)
- Zebrafish (1)
Applications
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (12)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (156)
- ES Cell Differentiation/IPS (60)
- Protein Kinase (53)
- Transmembrane (25)
- Secreted Protein (24)
- Transcription Factors (10)
- GPCR (6)
- Adult stem cells (4)
- Embryonic stem cells (3)
- Induced pluripotent stem cells (2)
- Stem cell relevant signaling - JAK/STAT signaling pathway (2)
- Cancer stem cells (1)
- Phosphatase (1)
- Stem cell - Pluripotency (1)
- Stem cell relevant signaling - DSL/Notch pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Cytokine-cytokine receptor interaction (13)
- Jak-STAT signaling pathway (11)
- Cell adhesion molecules (CAMs) (10)
- Focal adhesion (10)
- Hematopoietic cell lineage (10)
- Pathways in cancer (10)
- ECM-receptor interaction (9)
- Hypertrophic cardiomyopathy (HCM) (9)
- T cell receptor signaling pathway (9)
- Dilated cardiomyopathy (7)
- Toll-like receptor signaling pathway (7)
- Allograft rejection (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (6)
- Asthma (6)
- Regulation of actin cytoskeleton (6)
- Autoimmune thyroid disease (5)
- Complement and coagulation cascades (5)
- Small cell lung cancer (5)
- Systemic lupus erythematosus (5)
- Fc epsilon RI signaling pathway (4)
- NOD-like receptor signaling pathway (4)
- Neuroactive ligand-receptor interaction (4)
- Pathogenic Escherichia coli infection (4)
- Apoptosis (3)
- Gap junction (3)
- Graft-versus-host disease (3)
- MAPK signaling pathway (3)
- Prion diseases (3)
- Acute myeloid leukemia (2)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Antigen processing and presentation (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Cytosolic DNA-sensing pathway (2)
- Endocytosis (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Leukocyte transendothelial migration (2)
- Natural killer cell mediated cytotoxicity (2)
- Primary immunodeficiency (2)
- Prostate cancer (2)
- TGF-beta signaling pathway (2)
- B cell receptor signaling pathway (1)
- Bladder cancer (1)
- Cell cycle (1)
- Glioma (1)
- Insulin signaling pathway (1)
- Melanogenesis (1)
- Melanoma (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Pancreatic cancer (1)
- Progesterone-mediated oocyte maturation (1)
- RIG-I-like receptor signaling pathway (1)
- Renal cell carcinoma (1)
- Thyroid cancer (1)
- Tight junction (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- VEGF signaling pathway (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)
- mTOR signaling pathway (1)
- p53 signaling pathway (1)